Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision stamp updated from v3.5.3 to v3.5.4, representing a new release version of the site. The change does not modify visible content or study information on the page.
    Difference
    0.1%
    Check dated 2026-05-15T02:13:35.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.3, replacing the previous v3.5.2, indicating a backend build update with no changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T17:39:50.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.2 and removed v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:27:43.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:47:04.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    - The site revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:16:08.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    Added results metrics (pathologic complete response rate, overall survival, disease-free survival) and counts of drug-related toxicities with posting dates; included investigator/site details (Arsen Osipov, MD; Cedars-Sinai; The University of Texas Health Science Center at San Antonio) and attached the Study Protocol and Statistical Analysis Plan document.
    Difference
    3%
    Check dated 2026-02-11T01:46:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.